Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 747 entries
Sorted by: Best Match Show Resources per page
A call for data on the principal pipeline

pipeline programs

Perrone F, Young MD, Fuller EJ.
GSID: Gfisv3bPhLIJ
F Perrone, MD Young, EJ Fuller - Educational Researcher, 2021 - journals.sagepub.com

… pipeline—from entry to licensure programs to exiting from the profession—that would allow researchers to answer essential questions about the principal pipeline. … access to robust data on the principal pipeline. Next, we examine policy avenues to collect data...

Cite
Perrone, F., Young, M. D., & Fuller, E. J. (2021). A call for data on the principal pipeline. Educational Researcher, 0013189X221075767.
Perrone, Frank, Michelle D. Young, and Edward J. Fuller. "A call for data on the principal pipeline." Educational Researcher (2021): 0013189X221075767.
Copy Download .nbib Format: MLA
Diversity and dollars: productive diversity in Australian business and industry

diversity

Bertone S, Esposto A.
GSID: f3zMk82VMZIJ
S Bertone, R Turner, A Esposto - 1998 - Committee for Economic …

No abstract available.

Cite
Bertone, S., Turner, R., & Esposto, A. (1998). Diversity and dollars: Productive diversity in Australian business and industry (Vol. 58). Committee for Economic Development of Australia.
Bertone, Santina, Rodney Turner, and Alexis Esposto. Diversity and dollars: Productive diversity in Australian business and industry. Vol. 58. Committee for Economic Development of Australia, 1998.
Copy Download .nbib Format: MLA
Multiculturalism as a conservative ideology: Impacts on workforce diversity

workforce diversity

Bertone S, Leahy M.
GSID: qCntyDsTjrYJ
S Bertone, M Leahy - Asia Pacific Journal of Human Resources, 2003 - Wiley Online Library

This paper is critical of Australian multicultural policy and the way it has been applied to the workplace. It also questions the likely impact of recent government policy relating to asylum seekers and multiculturalism on diversity management generally. The...

Cite
Bertone, S., & Leahy, M. (2003). Multiculturalism as a conservative ideology: Impacts on workforce diversity. Asia Pacific Journal of Human Resources, 41(1), 101-115.
Bertone, Santina, and Mary Leahy. "Multiculturalism as a conservative ideology: Impacts on workforce diversity." Asia Pacific Journal of Human Resources 41.1 (2003): 101-115.
Copy Download .nbib Format: MLA
Differential serotonergic modulation of two types of aggression in weakly electric fish.

Frontiers in behavioral neuroscience

Zubizarreta L, Perrone R, Stoddard PK, Costa G, Silva AC.
PMID: 23181014
Front Behav Neurosci. 2012 Nov 19;6:77. doi: 10.3389/fnbeh.2012.00077. eCollection 2012.

Agonistic aggression has provided an excellent framework to study how conserved circuits and neurochemical mediators control species-specific and context-dependent behavior. The principal inhibitory control upon aggression is serotonin (5-HT) dependent, and the activation of 5-HT(1A) receptors is involved in...

Cite
Zubizarreta L, Perrone R, Stoddard PK, et al. Differential serotonergic modulation of two types of aggression in weakly electric fish. Front Behav Neurosci. 2012;6:77doi: 10.3389/fnbeh.2012.00077.
Zubizarreta, L., Perrone, R., Stoddard, P. K., Costa, G., & Silva, A. C. (2012). Differential serotonergic modulation of two types of aggression in weakly electric fish. Frontiers in behavioral neuroscience, 677. https://doi.org/10.3389/fnbeh.2012.00077
Zubizarreta, Lucía, et al. "Differential serotonergic modulation of two types of aggression in weakly electric fish." Frontiers in behavioral neuroscience vol. 6 (2012): 77. doi: https://doi.org/10.3389/fnbeh.2012.00077
Zubizarreta L, Perrone R, Stoddard PK, Costa G, Silva AC. Differential serotonergic modulation of two types of aggression in weakly electric fish. Front Behav Neurosci. 2012 Nov 19;6:77. doi: 10.3389/fnbeh.2012.00077. eCollection 2012. PMID: 23181014; PMCID: PMC3500767.
Copy Download .nbib Format: NLM
Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma.

The journal of pathology. Clinical research

Sonzogni A, Bianchi F, Fabbri A, Cossa M, Rossi G, Cavazza A, Tamborini E, Perrone F, Busico A, Capone I, Picciani B, Valeri B, Pastorino U, Pelosi G.
PMID: 28451462
J Pathol Clin Res. 2017 Mar 22;3(2):139-152. doi: 10.1002/cjp2.67. eCollection 2017 Apr.

Whether invasive mucinous adenocarcinoma (IMA) and colloid adenocarcinoma (ICA) of the lung represent separate tumour entities, or simply lie within a spectrum of phenotypic variability, is worth investigating. Fifteen ICA, 12 IMA, 9

Cite
Sonzogni A, Bianchi F, Fabbri A, et al. Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma. J Pathol Clin Res. 2017;3(2):139-152doi: 10.1002/cjp2.67.
Sonzogni, A., Bianchi, F., Fabbri, A., Cossa, M., Rossi, G., Cavazza, A., Tamborini, E., Perrone, F., Busico, A., Capone, I., Picciani, B., Valeri, B., Pastorino, U., & Pelosi, G. (2017). Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma. The journal of pathology. Clinical research, 3(2), 139-152. https://doi.org/10.1002/cjp2.67
Sonzogni, Angelica, et al. "Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma." The journal of pathology. Clinical research vol. 3,2 (2017): 139-152. doi: https://doi.org/10.1002/cjp2.67
Sonzogni A, Bianchi F, Fabbri A, Cossa M, Rossi G, Cavazza A, Tamborini E, Perrone F, Busico A, Capone I, Picciani B, Valeri B, Pastorino U, Pelosi G. Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma. J Pathol Clin Res. 2017 Mar 22;3(2):139-152. doi: 10.1002/cjp2.67. eCollection 2017 Apr. PMID: 28451462; PMCID: PMC5402180.
Copy Download .nbib Format: NLM
Laparoscopic Sleeve Gastrectomy versus Laparoscopic Banded Sleeve Gastrectomy: First Prospective Pilot Randomized Study.

Gastroenterology research and practice

Tognoni V, Benavoli D, Bianciardi E, Perrone F, Ippoliti S, Gaspari A, Gentileschi P.
PMID: 27143964
Gastroenterol Res Pract. 2016;2016:6419603. doi: 10.1155/2016/6419603. Epub 2016 Apr 10.

Introduction. The placement of ring or band around the gastric tube might prevent the dilation after Laparoscopic Sleeve Gastrectomy (LSG). We describe the first randomized study comparing LSG and Laparoscopic Banded Sleeve Gastrectomy (LBSG). Material and Method. Fifty obese...

Cite
Tognoni V, Benavoli D, Bianciardi E, et al. Laparoscopic Sleeve Gastrectomy versus Laparoscopic Banded Sleeve Gastrectomy: First Prospective Pilot Randomized Study. Gastroenterol Res Pract. 2016;2016:6419603doi: 10.1155/2016/6419603.
Tognoni, V., Benavoli, D., Bianciardi, E., Perrone, F., Ippoliti, S., Gaspari, A., & Gentileschi, P. (2016). Laparoscopic Sleeve Gastrectomy versus Laparoscopic Banded Sleeve Gastrectomy: First Prospective Pilot Randomized Study. Gastroenterology research and practice, 20166419603. https://doi.org/10.1155/2016/6419603
Tognoni, Valeria, et al. "Laparoscopic Sleeve Gastrectomy versus Laparoscopic Banded Sleeve Gastrectomy: First Prospective Pilot Randomized Study." Gastroenterology research and practice vol. 2016 (2016): 6419603. doi: https://doi.org/10.1155/2016/6419603
Tognoni V, Benavoli D, Bianciardi E, Perrone F, Ippoliti S, Gaspari A, Gentileschi P. Laparoscopic Sleeve Gastrectomy versus Laparoscopic Banded Sleeve Gastrectomy: First Prospective Pilot Randomized Study. Gastroenterol Res Pract. 2016;2016:6419603. doi: 10.1155/2016/6419603. Epub 2016 Apr 10. PMID: 27143964; PMCID: PMC4842065.
Copy Download .nbib Format: NLM
Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM).

ESMO open

Di Maio M, Bruzzi P, Perrone F, Torri V, Montemurro F, Tiseo M, Vasile E.
PMID: 28255452
ESMO Open. 2016 Dec 12;1(6):e000109. doi: 10.1136/esmoopen-2016-000109. eCollection 2016.

In oncology, as in other clinical fields, different treatments are often approved for the same therapeutic indication. In many cases, no direct comparisons are available to inform the choice in clinical practice. In 2015, the Italian Association of Medical...

Cite
Di Maio M, Bruzzi P, Perrone F, et al. Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM). ESMO Open. 2016;1(6):e000109doi: 10.1136/esmoopen-2016-000109.
Di Maio, M., Bruzzi, P., Perrone, F., Torri, V., Montemurro, F., Tiseo, M., & Vasile, E. (2016). Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM). ESMO open, 1(6), e000109. https://doi.org/10.1136/esmoopen-2016-000109
Di Maio, Massimo, et al. "Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)." ESMO open vol. 1,6 (2016): e000109. doi: https://doi.org/10.1136/esmoopen-2016-000109
Di Maio M, Bruzzi P, Perrone F, Torri V, Montemurro F, Tiseo M, Vasile E. Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM). ESMO Open. 2016 Dec 12;1(6):e000109. doi: 10.1136/esmoopen-2016-000109. eCollection 2016. PMID: 28255452; PMCID: PMC5174803.
Copy Download .nbib Format: NLM
Silver nanoparticle ink technology: state of the art.

Nanotechnology, science and applications

Rajan K, Roppolo I, Chiappone A, Bocchini S, Perrone D, Chiolerio A.
PMID: 26811673
Nanotechnol Sci Appl. 2016 Jan 11;9:1-13. doi: 10.2147/NSA.S68080. eCollection 2016.

Printed electronics will bring to the consumer level great breakthroughs and unique products in the near future, shifting the usual paradigm of electronic devices and circuit boards from hard boxes and rigid sheets into flexible thin layers and bringing...

Cite
Rajan K, Roppolo I, Chiappone A, et al. Silver nanoparticle ink technology: state of the art. Nanotechnol Sci Appl. 2016;9:1-13doi: 10.2147/NSA.S68080.
Rajan, K., Roppolo, I., Chiappone, A., Bocchini, S., Perrone, D., & Chiolerio, A. (2016). Silver nanoparticle ink technology: state of the art. Nanotechnology, science and applications, 91-13. https://doi.org/10.2147/NSA.S68080
Rajan, Krishna, et al. "Silver nanoparticle ink technology: state of the art." Nanotechnology, science and applications vol. 9 (2016): 1-13. doi: https://doi.org/10.2147/NSA.S68080
Rajan K, Roppolo I, Chiappone A, Bocchini S, Perrone D, Chiolerio A. Silver nanoparticle ink technology: state of the art. Nanotechnol Sci Appl. 2016 Jan 11;9:1-13. doi: 10.2147/NSA.S68080. eCollection 2016. PMID: 26811673; PMCID: PMC4714735.
Copy Download .nbib Format: NLM
Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimilars.

Biologics : targets & therapy

Perrone V, Saragoni S, Buda S, Broccoli A, Degli Esposti L.
PMID: 27942203
Biologics. 2016 Dec 01;10:157-165. doi: 10.2147/BTT.S114625. eCollection 2016.

AIM: The purpose of this study was to assess the prescription of epoetins and consumption of health care resources (in terms of drug treatments) in naïve patients with hematological malignancies in a real-world setting; in particular, we compared the...

Cite
Perrone V, Saragoni S, Buda S, et al. Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimilars. Biologics. 2016;10:157-165doi: 10.2147/BTT.S114625.
Perrone, V., Saragoni, S., Buda, S., Broccoli, A., & Degli Esposti, L. (2016). Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimilars. Biologics : targets & therapy, 10157-165. https://doi.org/10.2147/BTT.S114625
Perrone, Valentina, et al. "Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimilars." Biologics : targets & therapy vol. 10 (2016): 157-165. doi: https://doi.org/10.2147/BTT.S114625
Perrone V, Saragoni S, Buda S, Broccoli A, Degli Esposti L. Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimilars. Biologics. 2016 Dec 01;10:157-165. doi: 10.2147/BTT.S114625. eCollection 2016. PMID: 27942203; PMCID: PMC5137929.
Copy Download .nbib Format: NLM
Carcinoma of the lip five years after bone marrow transplantation.

Annali di stomatologia

Ardore M, Berrone M, Marchitto G, Gandolfo S, Pentenero M.
PMID: 27051476
Ann Stomatol (Roma). 2015 Dec 01;6:38. eCollection 2015.

No abstract available.

Cite
Ardore M, Berrone M, Marchitto G, et al. Carcinoma of the lip five years after bone marrow transplantation. Ann Stomatol (Roma). 2015;6:38
Ardore, M., Berrone, M., Marchitto, G., Gandolfo, S., & Pentenero, M. (2015). Carcinoma of the lip five years after bone marrow transplantation. Annali di stomatologia, 638.
Ardore, M, et al. "Carcinoma of the lip five years after bone marrow transplantation." Annali di stomatologia vol. 6 (2015): 38.
Ardore M, Berrone M, Marchitto G, Gandolfo S, Pentenero M. Carcinoma of the lip five years after bone marrow transplantation. Ann Stomatol (Roma). 2015 Dec 01;6:38. eCollection 2015. PMID: 27051476; PMCID: PMC4794634.
Copy Download .nbib Format: NLM
Epidemiology, patient profile, and health care resource use for hepatitis C in Italy.

ClinicoEconomics and outcomes research : CEOR

Sangiorgi D, Perrone V, Buda S, Boglione L, Cariti G, Lefevre C, Nappi C, Degli Esposti L.
PMID: 29066922
Clinicoecon Outcomes Res. 2017 Oct 10;9:609-616. doi: 10.2147/CEOR.S136456. eCollection 2017.

OBJECTIVE: The objectives of this study were to estimate the prevalence of Hepatitis C among six Italian Local Health Units (LHUs), to describe patient and antiviral drug characteristics, and to estimate the health care consumption rates and related costs...

Cite
Sangiorgi D, Perrone V, Buda S, et al. Epidemiology, patient profile, and health care resource use for hepatitis C in Italy. Clinicoecon Outcomes Res. 2017;9:609-616doi: 10.2147/CEOR.S136456.
Sangiorgi, D., Perrone, V., Buda, S., Boglione, L., Cariti, G., Lefevre, C., Nappi, C., & Degli Esposti, L. (2017). Epidemiology, patient profile, and health care resource use for hepatitis C in Italy. ClinicoEconomics and outcomes research : CEOR, 9609-616. https://doi.org/10.2147/CEOR.S136456
Sangiorgi, Diego, et al. "Epidemiology, patient profile, and health care resource use for hepatitis C in Italy." ClinicoEconomics and outcomes research : CEOR vol. 9 (2017): 609-616. doi: https://doi.org/10.2147/CEOR.S136456
Sangiorgi D, Perrone V, Buda S, Boglione L, Cariti G, Lefevre C, Nappi C, Degli Esposti L. Epidemiology, patient profile, and health care resource use for hepatitis C in Italy. Clinicoecon Outcomes Res. 2017 Oct 10;9:609-616. doi: 10.2147/CEOR.S136456. eCollection 2017. PMID: 29066922; PMCID: PMC5644550.
Copy Download .nbib Format: NLM
International Clinical Trials Day 2014-ancient and modern needs.

Ecancermedicalscience

Perrone F.
PMID: 24868245
Ecancermedicalscience. 2014 May 20;8:ed35. doi: 10.3332/ecancer.2014.ed35. eCollection 2014.

No abstract available.

Cite
Perrone F. International Clinical Trials Day 2014-ancient and modern needs. Ecancermedicalscience. 2014;8:ed35doi: 10.3332/ecancer.2014.ed35.
Perrone, F. (2014). International Clinical Trials Day 2014-ancient and modern needs. Ecancermedicalscience, 8ed35. https://doi.org/10.3332/ecancer.2014.ed35
Perrone, Francesco. "International Clinical Trials Day 2014-ancient and modern needs." Ecancermedicalscience vol. 8 (2014): ed35. doi: https://doi.org/10.3332/ecancer.2014.ed35
Perrone F. International Clinical Trials Day 2014-ancient and modern needs. Ecancermedicalscience. 2014 May 20;8:ed35. doi: 10.3332/ecancer.2014.ed35. eCollection 2014. PMID: 24868245; PMCID: PMC4030852.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 747 entries